Safety Assessment of Squalane and Squalene as Used in Cosmetics Status: Re-Review for Panel Review Release Date: March 15, 2019 Panel Meeting Date: April 8-9, 2019 The 2019 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D., Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Executive Director is Bart Heldreth, Ph.D. This safety assessment was prepared by Monice M. Fiume, Senior Director. © Cosmetic Ingredient Review 1620 L Street, NW, Suite 1200 ♢ Washington, DC 20036-4702 ♢ ph 202.331.0651 ♢ fax 202.331.0088 ♢
[email protected] Distributed for Comment Only -- Do Not Cite or Quote Commitment & Credibility since 1976 Memorandum To: CIR Expert Panel Members and Liaisons From: Monice M. Fiume MMF Senior Director Date: March 15, 2019 Subject: Re-Review of the Safety Assessment of Squalane and Squalene The CIR Expert Panel first reviewed the safety of Squalane and Squalene in 1982. The Panel concluded that “both Squalane and Squalene are safe as cosmetic ingredients in the present practices of use and concentration,” as described in that report (identified as squal042019orig in the pdf). In 2001, after considering new studies and updated use data on these two ingredients, the Panel determined to not re-open the safety assessment (squal042019RR1sum). The minutes from the Panel deliberations of that re-review are included (squal042019min_RR1).